Passage Bio Inc. (NASDAQ: PASG)
$0.8171
-0.0119 ( -0.23% ) 263.5K
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Data
Open
$0.8171
Previous close
$0.8290
Volume
263.5K
Market cap
$46.94M
Day range
$0.7660 - $0.8730
52 week range
$0.4510 - $1.7900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Aug 01, 2024 |
| 8-k | 8K-related | 15 | Jul 16, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 8-k | 8K-related | 13 | May 22, 2024 |
| 10-q | Quarterly Reports | 63 | May 14, 2024 |